Clinical and biological relevance of PML breakpoints in acute promyelocytic leukemia.

被引:0
|
作者
Khoury, H
Nevill, TJ
Dalal, BI
Shepherd, JD
Hogge, DE
Toze, CL
Conneally, EA
Sutherland, HJ
Nantel, SH
Barnett, MJ
Le, A
Brockington, DA
Vickars, LM
Horsman, DE
机构
[1] British Columbia Canc Agcy, Leukemia BMT Program, Div Hematol, Vancouver Gen Hosp, Vancouver, BC V5Z 4E6, Canada
[2] Vancouver Gen Hosp, Vancouver, BC, Canada
[3] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[5] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
454
引用
下载
收藏
页码:108A / 108A
页数:1
相关论文
共 50 条
  • [21] Arsenic trioxide and acute promyelocytic leukemia:: Clinical and biological
    Chen, Z.
    Zhao, W-L.
    Shen, Z-X.
    Li, J-M.
    Chen, S-J.
    Zhu, J.
    Lallemand-Breittenbach, V.
    Zhou, J.
    Guillemin, M-C.
    Vitoux, D.
    de The, H.
    ACUTE PROMYELOCYTIC LEUKEMIA: MOLECULAR GENETICS, MOUSE MODELS AND TARGETED THERAPY, 2007, 313 : 129 - 144
  • [22] Clonal evolution in a case of acute promyelocytic leukemia.
    Gottesman, SRS
    Babu, A
    Zeng, R
    Mizhiritskaya, V
    Macera, MJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 221 - 221
  • [23] Second primary maligancies in acute promyelocytic leukemia.
    Budhathoki, Nibash
    Shah, Binay Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Clinical relevance of angiogenic factors in patients with acute lymphoblastic leukemia.
    Albitar, M
    Aguilar, C
    Thomas, D
    Dey, A
    Giles, FJ
    Kantarjian, HM
    BLOOD, 2003, 102 (11) : 384A - 385A
  • [25] Use of flow cytometry in acute promyelocytic leukemia.
    Hadid, Tarik H.
    Sahovic, Entezam A.
    Lister, John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Monitoring PML-RARα in acute promyelocytic leukemia
    Joseph G. Jurcic
    Current Oncology Reports, 2003, 5 (5) : 391 - 398
  • [27] PML, A GROWTH SUPPRESSOR DISRUPTED IN ACUTE PROMYELOCYTIC LEUKEMIA
    MU, ZM
    CHIN, KV
    LIU, JH
    LOZANO, G
    CHANG, KS
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) : 6858 - 6867
  • [28] TARGETED DISRUPTION OF THE PML GENE OF ACUTE PROMYELOCYTIC LEUKEMIA
    PANDOLFI, PP
    BYGRAVE, A
    LINDENBAUM, M
    PELICCI, PG
    LUZZATTO, L
    GROSVELD, F
    BLOOD, 1993, 82 (10) : A191 - A191
  • [29] Mitoxantrone induces DNA topoisomerase II cleavage at translocation breakpoint hotspot in PML gene in acute promyelocytic leukemia.
    Mistry, AR
    Felix, CA
    Whitmarsh, R
    Mason, A
    Reiter, A
    Cassinat, B
    Parry, A
    Walz, C
    Ades, L
    Blair, IA
    Osheroff, N
    Littlewood, TJ
    Lafage-Pochitaloff, M
    Cross, NCP
    Chomienne, C
    Solomon, E
    Fenaux, P
    Grimwade, D
    BLOOD, 2003, 102 (11) : 215A - 215A
  • [30] Coexpression of PML/RARα and AML1/ETO leads to ATRA resistance in vivo in acute promyelocytic leukemia.
    Lima, RSAE
    Baruffi, MR
    Lima, ASG
    Figueiredo, LL
    Falcao, RP
    Chauffaille, MDF
    Rego, EM
    BLOOD, 2004, 104 (11) : 153B - 153B